Subsequent Events |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2025 | |||
| Subsequent Events [Abstract] | |||
| Subsequent Events |
In April 2025, the Company entered into a License and Supply Agreement (the “Aché License agreement”) with Aché Laboratórios Farmacêuticos S.A. (“Aché”) pursuant to which the Company granted to Aché an exclusive license to commercialize the Company’s TLANDO® product with respect to the Field, specific to Brazil (the “Aché territory”). Under the agreement, the Company is entitled to receive fees upon the achievement of certain regulatory milestones, royalties on net sales and will supply TLANDO to Aché at an agreed transfer price. |